مستشفى الملك المؤسس عبد الله الجامعي أكبر المستشفيات في شمال الأردن. يخدم حوالي أكثر من مليون مواطن في كل من إربد، عجلون، جرش والمفرق. يقع هذا المستشفى داخل حرم جامعة العلوم والتكنولوجيا الأردنية JUST وبمحاذاة كلية الطب في الجامعة ويعتبر مستشفى ذا ميزة تعليمية أيضا نظرا لارتباطه بجامعة العلوم والتكنولوجيا الأردنية.

During the past decade, King Abdullah University Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 6 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "King Abdullah University Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Jordan University of Science and Technology" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Elixir Medical Corporation" with 2 trials sponsored and "Al-Balqa Applied University" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "King Abdullah University Hospital" #1 collaborator was "Jordan University of Science and Technology" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "King Abdullah University Hospital" are "Coronary Artery Disease" (2 trials), "Crohn's Disease" (2 trials), "Vitamin D Deficiency" (2 trials), "Ageism" (1 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "King Abdullah University Hospital" in a lesser frequency.

Most popular intervention types in "King Abdullah University Hospital" are "Drug" (11 trials), "Biological" (4 trials), "Other" (4 trials), "Behavioral" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Guselkumab" (5 trials), "Golimumab" (2 trials), "Guselkumab Dose 1" (2 trials) and "Guselkumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "King Abdullah University Hospital" are 19 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "King Abdullah University Hospital". 1 are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in King Abdullah University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in King Abdullah University Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".